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Autism is considered as a neurodevelopmental disorder which affects boys more than girls, in a proportion 4:1 
respectively. Autism presents neuroanatomical abnormalities located in the frontal cortex, the amygdala and the 
cerebellum. Autistic cerebellar postmortem studies have revealed a reduced number of Purkinje cells as well as a 
reduced Purkinje cell size when compared with non-autistic subjects. These anatomical alterations compromise the role 
of the cerebellum in cognitive, motor, emotional, learning and memory neural processes resulting in a different 
interpretation of the world, and therefore a different way to respond and behave. There are both biological and 
environmental insults causing the behavioral and neuroanatomical autistic phenotype. Valproic acid, an antiepileptic drug, 
has been related to some autistic cases after mothers were under medication with this drug during the first trimester of 
gestation and given birth autistic children. Therefore, in this brief review we analyzed the most recent advances of 
autism research in humans, with a primary focus on the use of valproic acid as a teratogen that mimics in rats some of 
the neuroanatomical alterations seen in autistic humans. In addition to the peculiar cerebellar pathology, all of this to 
shed light on a better understating of this disorder.
Autism, Purkinje neuron, Valproic acid, Teratogenicity.
El autismo es un trastorno generalizado del desarrollo que afecta más a varones que mujeres, con una proporción de 4 a 
1, respectivamente. Dentro de sus características neuropatológicas más sobresalientes se encuentran la alteración 
anatómica de diversas estructuras del sistema nervioso central como la corteza frontal, la amígdala y el cerebelo. 
Estudios post mórtem en cerebelos de sujetos autistas han mostrado una notable disminución en el número de 
neuronas de Purkinje así como en su tamaño, comparado con las de sujetos sanos. Estas alteraciones anatómicas 
comprometen la participación del cerebelo en los procesos neurales como la cognición, actividad motora, la emoción, el 
aprendizaje y la memoria, dando como resultado una interpretación diferente del mundo que impacta sobre la respuesta 
y el comportamiento de los sujetos autistas. Actualmente se desconoce la causa de estas alteraciones anatómicas y 
aunque se avanza rápido en la ciencia se tiene la limitante de los sujetos experimentales, que en este caso son humanos. 
Por lo tanto, en esta revisión analizamos los hallazgos más relevantes de la patología cerebelar en el autismo, así como el 
uso del ácido valproico en ratas como teratógeno para simular alteraciones cerebelares como las observadas en autistas, 
contribuyendo a un mejor entendimiento de su neuropatología.
Autismo, Neurona de Purkinje, Ácido valproico, Teratógeno.
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The world prevalence of the Autism 
Spectrum Disorder (ASD) has increased 
from 0.7/10000 to 72.6/10000 (1966-2003) 
and the male/female ratio of affection is 4:1, 
respectively.1 The ASD involves different 
levels of alterations including the stereotypes 
and repetitive behavior, social interactions, 
communication and cognitive skills.2 Insights 
into autism have come from neuroanatomical 
analysis using magnetic resonance (MR) and 
postmortem studies, which have revealed 
morphological alterations in several areas of 
the central nervous system (CNS) (e.g., the 
frontal cortex, the amygdala and the 
cerebellum).3-6 Autistic brains show 
anatomical alterations in many areas of the 
limbic system including the hippocampus, the 
amygdala and the anterior cingulate gyrus, 
the septum as well as the prefrontal cortex 
and the cerebellum being the latter one of 
the most evident and commonly seen brain 
structure altered in autism. Originally, it was 
thought that the cerebellum participated only 
in motor skills; however, current research 
have shown the cerebellum to involve 
emotional processing, learning, memory, 
addiction, sexual reward, sexual behavior and 
communication.7-12 Despite the advances in 
understanding the cerebellar physiology, its 
involvement in complex disorders such as 
autism, is poorly understood leaving a 
number of unresolved questions worthy of 
investigation. Hence, we reviewed here some 
of the most relevant findings about the 
cerebellar pathology related to autism, and 
to discuss the use of valproic acid (VPA) in 
rats as an animal model for the study of 
cerebellar abnormalities in autism. 
The cerebellum contains different type of 
cells that are homogenously distributed in 
the entire cerebellar cortex. The most 
known cerebellar cells are the granule, 
stellate, basket, Golgi, Lugaro, unipolar brush 
and Purkinje neurons (Pkn) that all together 
constitute its neuronal circuitry and the 
three different layers (molecular, Purkinje 
and granular) of the cortex. The stellate, 
basket, Lugaro, Golgi and Purkinje are 
inhibitory whereas granule and brush cells 
are excitatory neurons. It is important to 
know that the gamma-amino butyric acid 
(GABA) is the main inhibitory 
neurotransmitter in the cerebellum;13,14,15
therefore the information processing 
requires an inhibition of the inhibition to 
allow sending the integrated information to 
the rest of the CNS. Also, the climbing and 
mossy fibers account for the excitatory 
inputs to the cerebellar cortex. The climbing 
fibers all come from the inferior olive and 
they form numerous synapses with the soma 
and dendrites of Pkn having a specific role 
during motor learning. Contrary, the mossy 
fibers mainly come from the vestibular and 
pontine nuclei establishing synapses with the 
granule cell dendrites.15 Pkn is the only 
output of the cerebellar cortex as well as the 
biggest cerebellar neuron, its cell bodies 
forms the Purkinje layer that is located in the 
middle of the cortex, with a dendritic tree 
that spreads out over the molecular layer to 
receive synaptic inputs from the stellate and 
basket interneurons as well as from the 
excitatory parallel fibers.13,14 The Pkn’s axon 
descends through the granular layer until 
reach the cerebellar deep nuclei and then 
sends the information to the rest of the 
brain, mainly to the basal ganglia, midbrain, 
motor cortex and the spinal cord.16 Based 
on the afferent connections to the 
cerebellum it can be subdivided in three main 
components: the vestibulocerebellum, the 
spinocerebellum and the cerebrocerebellum. 
The three components have specific 
functions and their afferent and efferent 
connections are from the same parts of the 
CNS. Thus, the vestibulocerebellum involves 
interactions between the vestibular nuclei 
and the flocculonodular lobe, the 
spinocerebellum involves connections 
between the anterior and posterior parts of 
the vermis and the spinal cord and the 
cerebrocerebellum implies connections 
between the cerebellar hemispheres and the 
cerebral cortex.15 The same anatomical and 
functional divergence covers the deep 
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cerebellar nuclei. Now, the human 
cerebellum presents ten different lobules.17
The rat cerebellum shows the same number 
of lobules8,9,18 than the human cerebellum 
and it has been used as a model for the study 
of the cerebellar physiology. Interestingly, 
although all the cerebellar lobules contain the 
same type of neurons (Figure 1) it has been 
shown that they respond differently to the 
same stimulus,8,10,11 suggesting that each 
cerebellar lobule has a separate participation 
during cerebellar tasks. 
Figure 1. This drawing represents the cytoarchitecture of the cerebellum. Its cellular components are: 1. Basket 
cells. 2. Climbing fibers. 3. Purkinje neurons. 4. Golgi cells. 5. Mossy fibers. 6. Stellate cells. 7. Parallel fibers. 8. 
Granule cells. 9. Lugaro cells. 10. Brush cells. Also, it shows the three different layers of cerebellar cortex: 
molecular layer (ML), Purkinje layer (PL) and granule layer (GL), as well as the white matter (WM). Arrows 
points out the ascending directions of the climbing (left) and mossy fibers (right) coming from the inferior olive 
and the brain, respectively. 
The Magnetic Resonance Imaging (MRI) has 
been a helpful tool for the study of 
neuroanatomical alterations in autism. 
Nevertheless, the results obtained from this 
technique are heterogeneous, possibly due to 
the complexity of this disorder. A study using 
3-4 years old autistic children revealed an 
enlarged cerebral volume compared with their 
age-matched control and more interestingly, 
the cerebellar volume was increased in 
proportion to the total cerebral volume.5
Furthermore, it has been reported that gray 
and white matter volumes were increased in 
autistic brains being the principal change in 
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both the cerebral and the cerebellar white 
matter.19 Then it seems there was an unusual 
pattern of brain growth in these autistic brains 
which may be related to growth factors or 
even to the neuronal sprouting process that is 
essential during the first year of life in humans, 
to organize the neuronal nuclei and neural 
circuitries in the brain. In addition, a study 
found that the brain weight of autistic children 
comprising ages from 5 to 13 years old was 
100 to 200 g heavier when comparing to 
controls. Opposite result was found in adult 
autistic subjects comprising ages from 18 to 54 
years old who showed brains lighter than the 
controls,20 which might indicate a degenerative 
process although this idea has to be 
determined. In contrast, a MRI study showed 
that children with autism spectrum disorder 
have reduced vermis volume as compared 
with their control, particularly the lobules VI 
to VII.21 Then, hyperplasia or hypoplasia could 
be found in autism. This structural feature 
seems to vary with age,19,22 although this trait 
is not unique of autism because other 
pathological conditions such as 
schizophrenia,23 Sotos syndrome, fragile X 
syndrome and Cole-Hughes macrocephaly 
syndrome24 also present abnormal head size 
and anomalies in specific brain areas involving 
limbic system and the cerebellum. More 
convincing data is needed in this field to 
continue in the pursuit of answers to telling us 
much more about the CNS, particularly the 
cerebellar development and its alterations. 
The most relevant postmortem finding in the 
cerebellum of autistic individuals is a reduction 
in the number of Pkn in the posterior lobe of 
the vermis and hemispheres 3,4,25-28 which 
differs in number between young and adult 
autistic subjects, being the older ones the 
most damaged, suggesting a neurodegenerative 
process.3,4 However, there is no report about 
abnormalities in the flocculonodular lobe of 
the autistic cerebellums. In addition, there is a 
variable decrease in the number of granule 
cells20 but basket and stellate cells are 
preserved.29 Moreover, other studies have 
revealed that Pkn size is smaller in autistic 
cerebellums compared with their matched 
controls,30 which might be related to some 
alterations of growth or neurotrophic factors 
which are involved in cell cycle, migration, cell 
differentiation and cell survival. Thus, any 
alteration on this set of cellular processes 
could be the responsible of Pkn abnormalities, 
modifying the integration of stimuli for a 
specific respond. Regarding the close 
relationship between Pkn and climbing fibers, it 
has been shown that there is a neuronal loss in 
the inferior olive of the autistic brainstem, an 
event that may occurs paralleling to the loss of 
Pkn in the cerebellum. 
One idea suggests that during the prenatal 
development, the CNS is insulted and this 
phenomenon compromises its maturation, 
therefore altering timeframes of development 
impacting on the cerebellar development and 
maturation, which begins prenatally and ends 
postnatally, respectively. This premise is based 
on the fact that cerebellar neuronal loss is not 
accompanied by gliosis4 indicating that the 
cerebellar damage occurs during the 
embryonic stage. As previously discussed, 
being Pkn the only cerebellar output either 
their reduced number or small size might 
change the information processing resulting in 
sending wrong signals to the rest of the brain, 
primarily to their first exchange information 
center, the deep cerebellar nuclei.15,16
In relation to the deep cerebellar nuclei 
(Figure 2) in the young autistic cerebellum, 
only the fastigial nucleus has shown a 
reduction in the number of neurons contrary 
to its neighbor nuclei.31 However, in older 
autistic patients neurons were reduced in 
number in the fastigial, emboliform and 
globose nuclei.20 Also, neurons in these 
cerebellar nuclei presented an enlarged size in 
autistic children whereas in adult subjects 
these neurons were smaller.4,20 Therefore, 
disturbances in Pkn and deep cerebellar nuclei 
surely change the way that the cerebellum 
communicates with the brain, the brainstem 
and the spinal cord. Moreover, there is 
information about neurochemical alterations in 
these cerebellar nuclei which involves 
neurotransmitters such as serotonin and 
GABA as well as synaptic and apoptotic 
proteins.
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Figure 2. This human cerebellum design shows the location of the deep cerebellar nuclei in the vermis and 
hemispheres from the middle to the lateral side. 
This new field has progressed in the last 10 
years and has produced interesting results. For 
example, expression of reelin, a protein that 
regulates neuronal migration in the early 
development and synaptic plasticity in the 
adulthood, and of Bcl-2, an apoptosis regulator 
protein, were reduced by 44% and 34% to 51% 
respectively, in the autistic cerebellum as 
compared with their matched sex, age and 
postmortem interval controls.32 Reduction of 
reelin has been associated with reduced levels 
of brain-derived neurotrophic factor 
(BDNF).33 Reelin is highly involved in the 
migration, a process that begins during 
gestation and ends months after birth, 
therefore any disturbance during this 
timeframe changes the normal cerebellar 
migration and the neuronal final location, 
compromising the way that neurons connect 
each other and certainly their physiology. In 
addition, glutamic acid decarboxylase (GAD) 
65 kDa and 67 kDa expression are reduced 
one half in the autistic cerebellar cortex.34
Specifically, both enzymes showed a reduced 
expression in Pkn but in basket cells were 
increased.35 Additionally, only GAD65 is 
diminished in the dentate nucleus of autistic 
cerebellums. Moreover, in autistic patients 
have been detected a mutation in the region 
that contains three GABAA receptor subunits 
( 5, 3, 3). It is known that GABA exerts 
trophic effects during the embryonic and 
perinatal development involving neuronal 
migration and neurite outgrowth.35 There is a 
possibility that these GABAergic alterations 
may be involved in the cause of autism instead 
of being a consequence of it. Hence, being the 
cerebellum a structure that works mainly with 
GABA, this neurochemical alteration could 
affect dramatically the cerebellar networks and 
produce the behavioral phenotype of autistic 
subjects. Also, nicotinic alpha4 receptor 
subunit is decreased whereas the alpha7 
subunit is increased.36 It has been established 
that nicotinic receptors play an important role 
in synaptic and dendritic plasticity as well as 
synthesis of some neurotrophins such as nerve 
growth factor (NGF), BDNF and fibroblast 
growth factor (FGF-2) influencing the neuronal 
connectivity and transmission. At a different 
molecular stage, mRNA levels of the gene 
encoding for the excitatory amino acid 
transporter 1 and glutamate receptor AMPA 1 
were significantly increased in the cerebellum 
of autistic individuals, whereas the AMPA-type 
glutamate density receptor was decreased.37
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Serotonin concentration is also altered in 
autistic brains. Particularly, in the autistic 
cerebellum, the right deep dentate nucleus 
presents an increased concentration of 
serotonin whereas in the frontal lobe is 
decreased.38 It is known that serotonin has 
trophic actions during brain development by 
regulating cell differentiation, neurite 
outgrowth and synaptogenesis.38 Therefore, 
any disruption on the levels of this 
neurotransmitter in the early deep cerebellar 
nuclei development may affect the neural 
network that connects the cerebellum with 
some limbic structures, being compromising 
cognitive and behavioral maturation in autism. 
Moreover, the blood level of serotonin is 
elevated in autistic subjects39 and some 
researchers think that this molecule could be a 
biomarker of autism for future diagnosis 
(Figure 3). 
Figure 3. This integrative framework depicts the main cerebellar alterations found in autistic subjects and tries 
to link them to the immediate neurobiological processes related with the cerebellar function and brain 
networks that may underlie part of the autistic phenotype. 
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Despite these particular alterations the lack 
of a biological biomarker is still there due to 
the complexity of this disorder that involves 
many factors. Up to now, we have shown the 
most relevant abnormalities in the autistic 
cerebellum going from the anatomical to 
neurochemical findings in order to look for 
the events or cues that tell us how the 
cerebellum is participating in autism, 
shedding light for a better understanding of 
this developmental pathology. Although the 
lack of information to understand autism, 
there is enough evidence supporting that the 
altered cerebellum has a significant 
contribution to autism. 
Obtaining brain samples from human beings 
with autism has been an important constraint 
for the advance of understanding this 
syndrome. Therefore, the development of 
animal models to contribute to the study of 
autism is quite necessary. Ingram et al (2000) 
published a paper showing a specific 
cerebellar alteration as seen in autism. They 
used VPA, an antiepileptic drug with a potent 
teratogenic activity during pregnancy,40-42
that mimics in rats the Pkn loss and volume 
abnormalities of the vermis and hemispheres 
as those seen in autism.43 Similar 
neuroanatomical abnormalities have been 
reported in mice under VPA treatment.44
VPA has been associated with autism since 
epileptic mothers were treated during 
pregnancy with sodium valproate (salt form 
of VPA) and gave birth to children with 
autism-like features.45-47 Other drugs such as 
misoprostol and thalidomide have been 
associated with the same effect. The 
experimental protocol followed by Ingram et 
al (2000) associates an abnormal 
development of the CNS to autism due to 
the insult given to embryonic rats during the 
closure of the neural tube (embryonic day 
11.5-12). In humans, this occurs on day 28 
after fecundation. In addition, the VPA-
treated rats have shown disruption in social 
interactions, altered levels of serotonin, 
different sensitivity to pain stimuli and 
repetitive and stereotype behavior43,48-50
such as those reported in autism. Taking data 
altogether, the use of VPA offers an 
opportunity for the study of the molecular 
and cellular mechanisms underlying the 
cerebellar development and its alterations, as 
well as their implications on social behavior 
and sensory integration in autism. Thus, the 
VPA model has the potential for being a 
useful tool on autism research. 
Here we summarized the most relevant 
alterations found in the autistic cerebellum. 
The complexity of this disorder and the 
limited number of brain samples has made 
difficult its study, remaining many questions 
unknown. Therefore, we emphasized the 
importance to develop animal models in 
order to understand the neuropathology of 
autism. Even though the VPA animal model 
needs to complete its validation, it could be a 
useful tool for the etiology of autism.
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